Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588952 · ClinicalTrials.gov registry record · NA
Ketamine/Placebo Family History Positive Study
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT00588952 is a NA study that has completed, run by Yale University. The registered enrollment target is 99 participants.
The verdict
NCT00588952, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may lead to the transition from moderate to excessive use of alcohol.
Interventions
- DRUG Ketamine and Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2001-03 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588952
The ClinicalTrials.gov registry entry for NCT00588952 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketamine and Placebo is the first listed.
NCT00588952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588952 about?
NCT00588952 is a clinical study titled "Ketamine/Placebo Family History Positive Study". The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may l...
What is the current status of trial NCT00588952?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2001-03. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00588952?
The interventions under investigation include: Ketamine and Placebo (DRUG).
Who is sponsoring clinical trial NCT00588952?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.